RedHill Biopharma Chief Business Officer Guy Goldberg, In Benzinga Interview, Says Co. Has No Set Financing Plan But Isn't 'Desperate For Cash,' Could Look At Offerings/Licensing Ex-U.S. Rights For Products Depending On Outcome Of Near Term Data Releases